3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
3
Rhabdomyosarcoma, Embryonal
3
Rhabdomyosarcoma
3
Rhabdomyosarcoma, Alveolar
2
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Pleuropulmonary blastoma
1
Histiocytoma, Malignant Fibrous
1
Dermatofibrosarcoma
1
Beckwith-Wiedemann Syndrome
1
Interventions
X-Rays
7
Phantoms, Imaging
7
Magnetic Resonance Spectroscopy
7
Specimen Handling
6
Nuclear Medicine Department, Hospital
5
Biopsy
4
tazemetostat
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Vincristine
2
Topotecan
2
Methotrexate
2
LY3023414
2
Etoposide
2
Cisplatin
2
Carboplatin
2
talazoparib
1
selinexor
1
pembrolizumab
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Dactinomycin
×
90 days
×
Clear all
No trials found.